Evnia in cooperation with ALL CARE GROUP, proudly announces the signing of a Memorandum of Understanding (MOU) with the Ministry of Health Saudi Arabia during CPhI Middle East to position Saudi Arabia as a Regional Hub for Biopharmaceuticals.
The new venture aims to advance Saudi Arabia’s leadership in the biopharmaceutical industry, aligning with the VISION 2030 goals and the National Biotechnology Program. This achievement highlights the shared vision to create the ”largest Biotechnology and Business accelerator in the MIddle East” and trust between the public and private sectors in driving regional leadership in biopharmaceutical innovation.
Based in Riyadh, Saudi Arabia, this biotech accelerator aims to become a key enabler towards Vision 2030 and the transformation of the Kingdom’s economy.
We would like to thank Mr. Sultan A. and Mrs. Galiya Potapchuk for this new chapter we jointly embark upon through our joined venture. In addition, we would like to deeply thank the Ministry of Health Saudi Arabia and his excellency, Minister of Health Fahad AlJalajel for supporting the partnership.
Vision 2030 is the most impactful project currently globally, and we are proud to be part of this transformation. Evnia’s vision has always to become the missing link between manufacturers, regulators and investors working for healthcare innovation and the improvement of patients’ quality of life by supporting solutions that address unmet medical needs. Our engagement in this venture will help us work towards these goals and to bring novel medical solutions to patients worldwide, developing a national system of innovation and expanding job creation and capabilities in the Biotechnology Sector.
A special thank you to Dr. Ian Proctor for the joined inspiring work and diligent input!
Dr. Efstathios Vassiliadis, CEO
